Reaction Details
Report a problem with these data
Report a problem with these dataTarget
Beta-3 adrenergic receptor
Ligand
BDBM50106813
Substrate
n/a
Meas. Tech.
ChEBML_39052
Ki
550±n/a nM
Citation
Washburn, WN; Sher, PM; Poss, KM; Girotra, RN; McCann, PJ; Gavai, AV; Mikkilineni, AB; Mathur, A; Cheng, P; Dejneka, TC; Sun, CQ; Wang, TC; Harper, TW; Russell, AD; Slusarchyk, DA; Skwish, S; Allen, GT; Hillyer, DE; Frohlich, BH; Abboa-Offei, BE; Cap, M; Waldron, TL; George, RJ; Tesfamariam, B; Ciosek, CP; Ryono, D; Young, DA; Dickinson, KE; Seymour, AA; Arbeeny, CM; Gregg, RE Beta 3 agonists. Part 1: evolution from inception to BMS-194449. Bioorg Med Chem Lett 11:3035-9 (2001) [PubMed] Article More Info.:
Target
Name:
Beta-3 adrenergic receptor
Synonyms:
ADRB3 | ADRB3R | ADRB3_HUMAN | B3AR | Beta-2 adrenergic receptor and beta-3 adrenergic receptor | Beta-3 adrenoceptor | Beta-3 adrenoreceptor | adrenergic Beta3
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
43534.88
Organism:
Homo sapiens (Human)
Description:
n/a
Residue:
408
Sequence:
MAPWPHENSSLAPWPDLPTLAPNTANTSGLPGVPWEAALAGALLALAVLATVGGNLLVIVAIAWTPRLQTMTNVFVTSLAAADLVMGLLVVPPAATLALTGHWPLGATGCELWTSVDVLCVTASIETLCALAVDRYLAVTNPLRYGALVTKRCARTAVVLVWVVSAAVSFAPIMSQWWRVGADAEAQRCHSNPRCCAFASNMPYVLLSSSVSFYLPLLVMLFVYARVFVVATRQLRLLRGELGRFPPEESPPAPSRSLAPAPVGTCAPPEGVPACGRRPARLLPLREHRALCTLGLIMGTFTLCWLPFFLANVLRALGGPSLVPGPAFLALNWLGYANSAFNPLIYCRSPDFRSAFRRLLCRCGRRLPPEPCAAARPALFPSGVPAARSSPAQPRLCQRLDGASWGVS
Inhibitor
Name:
BDBM50106813
Synonyms:
CHEMBL316546 | N-(5-{2-[2-(3,4-Dimethoxy-phenyl)-ethylamino]-1-hydroxy-ethyl}-2-hydroxy-phenyl)-methanesulfonamide
Type:
Small organic molecule
Emp. Form.:
C19H26N2O6S
Mol. Mass.:
410.485
SMILES:
COc1ccc(CCNCC(O)c2ccc(O)c(NS(C)(=O)=O)c2)cc1OC
Structure:
